Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Mannkind Corp (MNKD)

3.38   -0.24 (-6.63%) 03-05 08:57
Open: 3.61 Pre. Close: 3.62
High: 3.67 Low: 3.27
Volume: 7,981,936 Market Cap: 824M
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.676 - 3.701 3.701 - 3.721
Low: 3.209 - 3.24 3.24 - 3.265
Close: 3.335 - 3.379 3.379 - 3.413

Technical analysis

as of: 2021-03-05 8:13:39 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.97     One year: 7.30
Support: Support1: 3.27    Support2: 2.72
Resistance: Resistance1: 5.11    Resistance2: 6.25
Pivot: 5.08
Moving Average: MA(5): 4.10     MA(20): 5.12
MA(100): 3.36     MA(250): 2.26
MACD: MACD(12,26): -0.04     Signal(9): 0.29
Stochastic oscillator: %K(14,3): 2.78     %D(3): 10.88
RSI: RSI(14): 36.87
52-week: High: 6.25  Low: 0.80  Change(%): 152.2
Average Vol(K): 3-Month: 622706  10-Days: 1065369

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MNKD has closed above bottom band by 1.2%. Bollinger Bands are 204.8% wider than normal. The large width of the bands suggest high volatility as compared to MNKD's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
MannKind Corporation (MNKD) Plunges 6.63% on March 04 -

Tue, 02 Mar 2021
MannKind Corporation: Bullish On High-Growth Inhaled Insulin Opportunity - Seeking Alpha

Mon, 01 Mar 2021
Can You Imagine How Elated MannKind's (NASDAQ:MNKD) Shareholders Feel About Its 350% Share Price Gain? - Yahoo Finance

Fri, 26 Feb 2021
MannKind Corporation (MNKD) Soars 1.78% on February 26 -

Thu, 25 Feb 2021
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results - Yahoo Finance

Fri, 19 Feb 2021
Insiders Seeing Green With MNKD At New 52-Week High - Nasdaq

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 236
Shares Float (M) 222
% Held by Insiders 4.86
% Held by Institutions 29.95
Shares Short (K) 17,190
Shares Short P. Month (K) 18,010

Stock Financials

EPS -0.209
EPS Est This Year -0.910
EPS Est Next Year -0.760
Book Value (p.s.) -0.810
Profit Margin -71.92
Operating Margin -43.14
Return on Assets (ttm) -17.7
Return on Equity (ttm)
Qtrly Rev. Growth 5.2
Gross Profit (p.s.) 0.149
Sales Per Share 0.266
EBITDA (p.s.) -0.107
Qtrly Earnings Growth
Operating Cash Flow (M) -33
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -16.17
PEG Ratio
Price to Book value -4.17
Price to Sales 12.71
Price to Cash Flow -23.80

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.